Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study
- PMID: 23345072
- PMCID: PMC3631078
- DOI: 10.1007/s11606-012-2320-1
Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study
Abstract
Background: Cardiovascular disease (CVD) prevention in diabetes requires broad-based treatment of dyslipidemia, hypertension, and hyperglycemia. The independent contribution of all combinations of risk factor control to CVD risk has not been evaluated.
Objective: To estimate the independent association of control of glycosylated hemoglobin (A1C), systolic blood pressure (SBP), and low-density lipoprotein cholesterol (LDL-C) with risk of cardiovascular disease hospitalization.
Design: Non-concurrent longitudinal cohort study.
Patients: The study included 26,636 patients with type 2 diabetes who were members of an integrated group model HMO with multiple A1C, SBP, and LDL-C measurements.
Main measures: Patients were followed for a mean (SD) of 5.6 (2.5) years until they died or disenrolled, or until 31 December 2010. The outcome was a first-observed CVD hospitalization. Using the mean of all A1C, SBP, and LDL-C measures during follow-up, we created dichotomous categories of A1C control (< 7 %), SBP control (< 130 mmHg), and LDL-C control (< 100 mg/dL) to estimate the incidence rate of CVD hospitalization associated with all combinations of risk factor control adjusting for demographic and clinical characteristics.
Key results: Patients with no controlled risk factors (18.2/1,000 person-years, 95 % CI 16.5-20.2) or with only A1C in control (16.9, 15.0-19.0) had the highest rate of CVD hospitalization, whereas those with all three risk factors controlled (7.2, 6.2-8.4) or with SBP and LDL-C in control (6.1, 5.1-7.2) had the lowest rates. Those with only SBP or LDL-C in control, A1C and SBP controlled, or A1C and LDL-C controlled had statistically similar incidence between the highest and lowest rates.
Conclusions: Maintaining SBP < 130 mmHg or LDL-C < 100 mg/dL was significantly associated with reduced CVD hospitalization risk, especially when both risk factors were well controlled. Maintaining A1C < 7 % was not independently associated with reduced CVD hospitalization risk.
Figures
Similar articles
-
Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.J Am Heart Assoc. 2017 Aug 17;6(8):e006400. doi: 10.1161/JAHA.117.006400. J Am Heart Assoc. 2017. PMID: 28862945 Free PMC article.
-
Potentially modifiable metabolic factors and the risk of cardiovascular disease hospitalizations in urban African Americans with diabetes.Ethn Dis. 2006 Autumn;16(4):852-8. Ethn Dis. 2006. PMID: 17061737
-
Maintenance of Clinical Endpoints After Discharge from a Pharmacist-Managed Risk Reduction Clinic at a Veterans Affairs Medical Center.J Manag Care Spec Pharm. 2016 Jan;22(1):14-20. doi: 10.18553/jmcp.2016.22.1.14. J Manag Care Spec Pharm. 2016. PMID: 27015047 Free PMC article.
-
Intensive glycaemic control in type 2 diabetes mellitus: does it improve cardiovascular outcomes?Natl Med J India. 2011 Jan-Feb;24(1):21-7. Natl Med J India. 2011. PMID: 21608354 Review.
-
Vegetarian Dietary Patterns and Cardiometabolic Risk in People With or at High Risk of Cardiovascular Disease: A Systematic Review and Meta-analysis.JAMA Netw Open. 2023 Jul 3;6(7):e2325658. doi: 10.1001/jamanetworkopen.2023.25658. JAMA Netw Open. 2023. PMID: 37490288 Free PMC article.
Cited by
-
Diagnostic Utility of Serum Glycated Albumin for Diabetes Mellitus and Its Correlation With Hyperlipidemia.Ann Lab Med. 2016 Jul;36(4):306-12. doi: 10.3343/alm.2016.36.4.306. Ann Lab Med. 2016. PMID: 27139602 Free PMC article.
-
A prediction model for diabetes complications using the Kokuho Database and its application to public health services in Japan.J Diabetes Investig. 2025 Jun;16(6):1091-1099. doi: 10.1111/jdi.70035. Epub 2025 Apr 2. J Diabetes Investig. 2025. PMID: 40172230 Free PMC article.
-
Economic evaluation of a pharmaceutical care program for elderly diabetic and hypertensive patients in primary health care: a 36-month randomized controlled clinical trial.J Manag Care Spec Pharm. 2015 Jan;21(1):66-75. doi: 10.18553/jmcp.2015.21.1.66. J Manag Care Spec Pharm. 2015. PMID: 25562774 Free PMC article. Clinical Trial.
-
Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study.J Am Pharm Assoc (2003). 2014 Jul-Aug;54(4):374-82. doi: 10.1331/JAPhA.2014.13195. J Am Pharm Assoc (2003). 2014. PMID: 24860866 Free PMC article.
-
Both high and low HbA1c predict incident heart failure in type 2 diabetes mellitus.Circ Heart Fail. 2015 Mar;8(2):236-42. doi: 10.1161/CIRCHEARTFAILURE.113.000920. Epub 2015 Jan 5. Circ Heart Fail. 2015. PMID: 25561089 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical